PHGE.WS
BiomX Inc. Warrants to purchase one-half of a share of Common Stock
PHGE.WS
PHGE.WS
Delisted
PHGE.WS was delisted on the 1st of June, 2023.
About: BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis.
Employees: 65
Charts implemented using
Lightweight Charts™